Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life

Información del proyecto

SERENITY

Identificador del acuerdo de subvención: 101057292

DOI

10.3030/101057292

Fecha de la firma de la CE 24 Mayo 2022

Fecha de inicio 1 Octubre 2022

Fecha de finalización 30 Septiembre 2027

Financiado con arreglo a

• Health

Coste total

€ 4 483 532,50

Aportación de la UE

€ 4 483 530,50

Coordinado por

ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Documents, reports (2)

Midterm progress report on realist review

The midterm progress report will summarise the fundings half way the duration of this particular study. The final manuscript will be ready for submission by month 12. The results of the review are used to inform the creators of the shared decision support tool(WP5) as well as the methodology for the RCT (WP6).

Report on findings of the realist review on PROSPERO

This report will summarise the findings of the realist review. The results of the review are used to inform the creators of the shared decision support tool (WP5) as well as the methodology for the RCT (WP6).

Websites, patent fillings, videos etc. (1)

Project website and logo

Both a project logo and website will be designed as described in section 2.2 and launched within the first 3 months of the project.

Publicaciones

Peer reviewed articles (9)

Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study

Autores: Mette Søgaard, Marie Ørskov, Martin Jensen, Jamilla Goedegebuur, Eva K. Kempers, Chantal Visser, Eric C.T. Geijteman, Denise Abbel, Simon P. Mooijaart, Geert-Jan Geersing, Johanneke Portielje, Adrian Edwards, Sarah J. Aldridge, Ashley Akbari, Anette A. Højen, Frederikus A. Klok, Simon Noble, Suzanne Cannegieter, Anne Gulbech Ording
Publicado en: Journal of Thrombosis and Haemostasis, Edición 23, 2025, ISSN 1538-7836
Editor: Elsevier BV
DOI: 10.1016/J.JTHA.2024.09.023

“Who am I to say that I'm not going to take it”: patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer

Autores: Elin Baddeley, Carme Font, Isabelle Mahé, Michelle Edwards, Stephanie Sivell, Kate J. Lifford, Victoria Mailen Arfuch, Nuri Coma-Auli, Mette Søgaard, Helle Enggaard, Hélène Helfer, Nassima Si Mohammed, Kathy Seddon, Mark Pearson, Simone P. Mooijaart, Sebastian Szmit, F.A. Klok, Simon Noble, Anette Arbjerg Højen
Publicado en: Thrombosis Research, Edición 253, 2025, ISSN 0049-3848
Editor: Elsevier BV
DOI: 10.1016/J.THROMRES.2025.109399

Anti‐thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: A cohort study using population‐linked routinely collected data

Autores: Sarah J. Aldridge, Ashley Akbari, Adrian Edwards, Kate J. Lifford, Denise Abbel, Suzanne Cannegieter, Jamilla Goedegebuur, Eva K. Kempers, Mette Søgaard, Chantal Visser, Geert‐Jan Geersing, Marieke J. H. Kruip, Anne Gulbech Ording, Carline van den Dries, Eric C. T. Geijteman, Erik Klok, Isabelle Mahé, Simon P. Mooijaart, Sebastian Szmit, Simon Noble
Publicado en: British Journal of Haematology, 2025, ISSN 0007-1048
Editor: Wiley
DOI: 10.1111/BJH.70032

Thrombosis Research

Autores: J, Goedegebuur; D, Abbel; F A, Klok; S I R, Noble
Publicado en: Scientia, 2023, ISSN 0049-3848
Editor: Pergamon Press
DOI: 10.1016/j.thromres.2023.05.008

Quality of vitamin K antagonist treatment during the last year of life

Autores: Chantal Visser, Eva K. Kempers, Jamilla Goedegebuur, Denise Abbel, Sarah J. Aldridge, Adrian Edwards, Michelle Edwards, Geert‐Jan Geersing, Anne Gulbech Ording, Sjef J. C. M. van de Leur, Kate J. Lifford, Isabelle Mahé, Simon P. Mooijaart, Melchior C. Nierman, Johanneke E. A. Portielje, Mette Søgaard, Sebastian Szmit, Nynke M. Wiersma, Simon I. R. Noble, Frederikus A. Klok, Qingui Chen, Suzanne C. Cannegieter, Eric C. T. Geijteman, Marieke J. H. A. Kruip, null null
Publicado en: HemaSphere, Edición 9, 2025, ISSN 2572-9241
Editor: Wiley
DOI: 10.1002/HEM3.70135

Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting Disease

Autores: Eva K. Kempers, Chantal Visser, Eric C. T. Geijteman, Jamilla Goedegebuur, Johanneke E. A. Portielje, Mette Søgaard, Anne Gulbech Ording, Carline van den Dries, Denise Abbel, Geert-Jan Geersing, Sarah J. Aldridge, Kate J. Lifford, Ashley Akbari, Sjef J. C. M. van de Leur, Melchior C. Nierman, Isabelle Mahé, Simon P. Mooijaart, Sebastian Szmit, Michelle Edwards, Simon I. R. Noble, Frederikus A. Klok, Qingui Chen, Suzanne C. Cannegieter, Marieke J. H. A. Kruip, null null
Publicado en: Thrombosis and Haemostasis, 2025, ISSN 0340-6245
Editor: Georg Thieme Verlag KG
DOI: 10.1055/A-2524-5334

Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer

Autores: E.S.L. Martens, D. Becker, C. Abele, D. Abbel, W.P. Achterberg, J.J. Bax, L. Bertoletti, M.E. Edwards, C. Font, A. Gava, J. Goedegebuur, A.A. Højen, M.V. Huisman, M.J.H.A. Kruip, I. Mahé, S.P. Mooijaart, M. Pearson, K. Seddon, S. Szmit, S.I.R. Noble, F.A. Klok, S.V. Konstantinides
Publicado en: Thrombosis Research, Edición 245, 2024, ISSN 0049-3848
Editor: Elsevier BV
DOI: 10.1016/j.thromres.2024.109205

Involving patients and the public in cancer associated thrombosis research: A strategy for success

Autores: Michelle Edwards, Kathy Seddon, Elin Baddeley, Anne Gulbech Ording, Mark Pearson, Isabelle Mahe, Simon Mooijaart, Frederikus A. Klok, Simon I.R. Noble
Publicado en: Thrombosis Update, Edición 18, 2025, ISSN 2666-5727
Editor: Elsevier BV
DOI: 10.1016/j.tru.2024.100196

Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis

Autores: Justin Jagosh, Mark Pearson, Sarah Greenley, Anthony Maraveyas, Gamze Keser, Fliss E. M. Murtagh, Simon Noble, Michelle Edwards, Adrian Edwards, Anette Arbjerg Højen, Kathy Seddon, Frederikus A. Klok, Simon P. Mooijaart, Eric C. T. Geijteman, Miriam J. Johnson
Publicado en: PLOS Medicine, Edición 22, 2025, ISSN 1549-1676
Editor: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PMED.1004663